Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

EyeTechCare SA brings in €10mm through its Series C venture round

Executive Summary

EyeTechCare SA (ultrasound-based ophthalmic devices) has raised €10mm ($13mm) through its Series C venture round. Private investor Bernard Chauvin, MD, participated (and will take a seat on the company’s board) alongside current shareholders Omnes Capital (formerly Credit Agricole Private Equity) and SHAM. EyeTechCare will use the new money to finish the EyeMUST 2 international trial of its EYEOP1 device for glaucoma; results are expected to be published next year. Some of the funds will also be used to begin the FDA registration process.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies